Doxorubicin Hydrochloride
- Product NDC
- 47335-050
- 11-digit product format
- 473350050
- Labeler code
- 47335
- Product ID
- 47335-050_efff8fef-d079-4581-8027-646e57a23c62
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- Doxorubicin Hydrochloride
- Dosage form
- INJECTABLE, LIPOSOMAL
- Route
- INTRAVENOUS
- Labeler
- Sun Pharmaceutical Industries, Inc.
- Application
- ANDA203263
- Marketing category
- ANDA
- Marketing start
- 2013-02-05
- Substance
- DOXORUBICIN HYDROCHLORIDE
- Active strength
- 2 mg/mL
- Pharmacologic classes
- Anthracycline Topoisomerase Inhibitor [EPC], Anthracyclines [CS], Topoisomerase Inhibitors [MoA]
- NDC exclude flag
- No
- Listing certified through
- 2027-12-31
- Current FDA listing
- Yes
Additional Listing Data#
- Finished product
- Yes
- Brand name base
- Doxorubicin Hydrochloride
- Listing expiration
- 2027-12-31
Active Ingredients#
Ingredient, Strength table| Ingredient | Strength |
|---|
| DOXORUBICIN HYDROCHLORIDE | 2 mg/mL |
Harmonized Identifiers#
Field, Values table| Field | Values |
|---|
| Unii | 82F2G7BL4E |
| Rxcui | 1790115, 1790127 |
DailyMed Product Concepts#
DailyMed Package Descriptions#
Package NDC, Product, Description table| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|
| 47335-050-40 | Doxorubicin Hydrochloride | 1 in 1 PACKAGE | INJECTABLE, LIPOSOMAL | 1 | | 24 |
| 47335-050-40 | Doxorubicin Hydrochloride | 25 mL in 1 VIAL, SINGLE-DOSE | INJECTABLE, LIPOSOMAL | 25 | | 24 |
DailyMed Socrata Ingredients#
Ingredient, Type, UNII table| Ingredient | Type | UNII | DailyMed label | SPL version | Uploaded |
|---|
| DOXORUBICIN HYDROCHLORIDE | ACTIVE INGREDIENT | 82F2G7BL4E | DOXORUBICIN HYDROCHLORIDE INJECTABLE, LIPOSOMAL [SUN PHARMA GLOBAL FZE] | 10 | |
| DOXORUBICIN | ACTIVE MOIETY | 80168379AG | DOXORUBICIN HYDROCHLORIDE INJECTABLE, LIPOSOMAL [SUN PHARMA GLOBAL FZE] | 10 | |
| AMMONIUM SULFATE | INACTIVE INGREDIENT | SU46BAM238 | DOXORUBICIN HYDROCHLORIDE INJECTABLE, LIPOSOMAL [SUN PHARMA GLOBAL FZE] | 10 | |
| CHOLESTEROL | INACTIVE INGREDIENT | 97C5T2UQ7J | DOXORUBICIN HYDROCHLORIDE INJECTABLE, LIPOSOMAL [SUN PHARMA GLOBAL FZE] | 10 | |
| HISTIDINE | INACTIVE INGREDIENT | 4QD397987E | DOXORUBICIN HYDROCHLORIDE INJECTABLE, LIPOSOMAL [SUN PHARMA GLOBAL FZE] | 10 | |
| HYDROCHLORIC ACID | INACTIVE INGREDIENT | QTT17582CB | DOXORUBICIN HYDROCHLORIDE INJECTABLE, LIPOSOMAL [SUN PHARMA GLOBAL FZE] | 10 | |
| HYDROGENATED SOYBEAN LECITHIN | INACTIVE INGREDIENT | H1109Z9J4N | DOXORUBICIN HYDROCHLORIDE INJECTABLE, LIPOSOMAL [SUN PHARMA GLOBAL FZE] | 10 | |
| N-(CARBONYL-METHOXYPOLYETHYLENE GLYCOL 2000)-1,2-DISTEAROYL-SN-GLYCERO-3-PHOSPHOETHANOLAMINE, SODIUM SALT | INACTIVE INGREDIENT | 3L6NN8ZZKU | DOXORUBICIN HYDROCHLORIDE INJECTABLE, LIPOSOMAL [SUN PHARMA GLOBAL FZE] | 10 | |
| SODIUM HYDROXIDE | INACTIVE INGREDIENT | 55X04QC32I | DOXORUBICIN HYDROCHLORIDE INJECTABLE, LIPOSOMAL [SUN PHARMA GLOBAL FZE] | 10 | |
| SUCROSE | INACTIVE INGREDIENT | C151H8M554 | DOXORUBICIN HYDROCHLORIDE INJECTABLE, LIPOSOMAL [SUN PHARMA GLOBAL FZE] | 10 | |
DailyMed Dashboard NDC Coverage#
NDC, Dashboard title, SPL version table| NDC | Dashboard title | SPL version | Validation | Dashboard ZIP |
|---|
| 47335-050 | DOXORUBICIN HYDROCHLORIDE INJECTABLE, LIPOSOMAL [SUN PHARMACEUTICAL INDUSTRIES, INC.] | 23 | Current NDC, Legacy NDC, 2 package rows | 20250411_fbc48fa5-0bfb-4957-b13c-a56bb7a13b56.zip |
DailyMed RxNorm Mappings#
Packages#
Package NDC, 11-digit format, Description table| Package NDC | 11-digit format | Description | Marketing start | Marketing end | Sample | Exclude flag | Status |
|---|
| 47335-050-40 | 47335005040 | 1 VIAL, SINGLE-DOSE in 1 PACKAGE (47335-050-40) / 25 mL in 1 VIAL, SINGLE-DOSE | 2013-02-05 | 0000-00-00 | No | No | Current |